BACKGROUND: Genome-wide association studies have identified determinants of chronic obstructive pulmonary disease, asthma, and lung function level; however, none have addressed decline in lung function. OBJECTIVE: We conducted the first genome-wide association study on the age-related decrease in FEV(1) and its ratio to forced vital capacity (FVC) stratified a priori by asthma status. METHODS: Discovery cohorts included adults of European ancestry (1,441 asthmatic and 2,677 nonasthmatic participants: the Epidemiological Study on the Genetics and Environment of Asthma, the Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults, and the European Community Respiratory Health Survey). The associations of FEV(1) and FEV(1)/FVC ratio decrease with 2.5 million single nucleotide polymorphisms (SNPs) were estimated. Thirty loci were followed up by in silico replication (1,160 asthmatic and 10,858 nonasthmatic participants: Atherosclerosis Risk in Communities, the Framingham Heart Study, the British 1958 Birth Cohort, and the Dutch Asthma Study). RESULTS: Main signals identified differed between asthmatic and nonasthmatic participants. None of the SNPs reached genome-wide significance. The association between the height-related gene DLEU7 and FEV(1) decrease suggested for nonasthmatic participants in the discovery phase was replicated (discovery, P = 4.8 × 10(-6); replication, P = .03), and additional sensitivity analyses point to a relation to growth. The top ranking signal, TUSC3, which is associated with FEV(1)/FVC ratio decrease in asthmatic participants (P = 5.3 × 10(-8)), did not replicate. SNPs previously associated with cross-sectional lung function were not prominently associated with decline. CONCLUSIONS: Genetic heterogeneity of lung function might be extensive. Our results suggest that genetic determinants of longitudinal and cross-sectional lung function differ and vary by asthma status.
BACKGROUND: Genome-wide association studies have identified determinants of chronic obstructive pulmonary disease, asthma, and lung function level; however, none have addressed decline in lung function. OBJECTIVE: We conducted the first genome-wide association study on the age-related decrease in FEV(1) and its ratio to forced vital capacity (FVC) stratified a priori by asthma status. METHODS: Discovery cohorts included adults of European ancestry (1,441 asthmatic and 2,677 nonasthmatic participants: the Epidemiological Study on the Genetics and Environment of Asthma, the Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults, and the European Community Respiratory Health Survey). The associations of FEV(1) and FEV(1)/FVC ratio decrease with 2.5 million single nucleotide polymorphisms (SNPs) were estimated. Thirty loci were followed up by in silico replication (1,160 asthmatic and 10,858 nonasthmatic participants: Atherosclerosis Risk in Communities, the Framingham Heart Study, the British 1958 Birth Cohort, and the Dutch Asthma Study). RESULTS: Main signals identified differed between asthmatic and nonasthmatic participants. None of the SNPs reached genome-wide significance. The association between the height-related gene DLEU7 and FEV(1) decrease suggested for nonasthmatic participants in the discovery phase was replicated (discovery, P = 4.8 × 10(-6); replication, P = .03), and additional sensitivity analyses point to a relation to growth. The top ranking signal, TUSC3, which is associated with FEV(1)/FVC ratio decrease in asthmatic participants (P = 5.3 × 10(-8)), did not replicate. SNPs previously associated with cross-sectional lung function were not prominently associated with decline. CONCLUSIONS: Genetic heterogeneity of lung function might be extensive. Our results suggest that genetic determinants of longitudinal and cross-sectional lung function differ and vary by asthma status.
Authors: X Xu; Z Fang; B Wang; C Chen; W Guang; Y Jin; J Yang; S Lewitzky; A Aelony; A Parker; J Meyer; S T Weiss; X Xu Journal: Am J Hum Genet Date: 2001-10-22 Impact factor: 11.025
Authors: Cleo C van Diemen; Dirkje S Postma; Judith M Vonk; Marcel Bruinenberg; Jan P Schouten; H Marike Boezen Journal: Am J Respir Crit Care Med Date: 2005-05-05 Impact factor: 21.405
Authors: Michael H Cho; Nadia Boutaoui; Barbara J Klanderman; Jody S Sylvia; John P Ziniti; Craig P Hersh; Dawn L DeMeo; Gary M Hunninghake; Augusto A Litonjua; David Sparrow; Christoph Lange; Sungho Won; James R Murphy; Terri H Beaty; Elizabeth A Regan; Barry J Make; John E Hokanson; James D Crapo; Xiangyang Kong; Wayne H Anderson; Ruth Tal-Singer; David A Lomas; Per Bakke; Amund Gulsvik; Sreekumar G Pillai; Edwin K Silverman Journal: Nat Genet Date: 2010-02-21 Impact factor: 38.330
Authors: Marilyn C Cornelis; Arpana Agrawal; John W Cole; Nadia N Hansel; Kathleen C Barnes; Terri H Beaty; Siiri N Bennett; Laura J Bierut; Eric Boerwinkle; Kimberly F Doheny; Bjarke Feenstra; Eleanor Feingold; Myriam Fornage; Christopher A Haiman; Emily L Harris; M Geoffrey Hayes; John A Heit; Frank B Hu; Jae H Kang; Cathy C Laurie; Hua Ling; Teri A Manolio; Mary L Marazita; Rasika A Mathias; Daniel B Mirel; Justin Paschall; Louis R Pasquale; Elizabeth W Pugh; John P Rice; Jenna Udren; Rob M van Dam; Xiaojing Wang; Janey L Wiggs; Kayleen Williams; Kai Yu Journal: Genet Epidemiol Date: 2010-05 Impact factor: 2.135
Authors: Antoon Dijkstra; Timothy D Howard; Judith M Vonk; Elizabeth J Ampleford; Leslie A Lange; Eugene R Bleecker; Deborah A Meyers; Dirkje S Postma Journal: J Allergy Clin Immunol Date: 2006-02-15 Impact factor: 10.793
Authors: Edwin K Silverman; Lyle J Palmer; Jonathan D Mosley; Matthew Barth; Jody M Senter; Alison Brown; Jeffrey M Drazen; David J Kwiatkowski; Harold A Chapman; Edward J Campbell; Michael A Province; D C Rao; John J Reilly; Leo C Ginns; Frank E Speizer; Scott T Weiss Journal: Am J Hum Genet Date: 2002-03-25 Impact factor: 11.025
Authors: Neil Caporaso; Fangyi Gu; Nilanjan Chatterjee; Jin Sheng-Chih; Kai Yu; Meredith Yeager; Constance Chen; Kevin Jacobs; William Wheeler; Maria Teresa Landi; Regina G Ziegler; David J Hunter; Stephen Chanock; Susan Hankinson; Peter Kraft; Andrew W Bergen Journal: PLoS One Date: 2009-02-27 Impact factor: 3.240
Authors: John M Brehm; Sze Man Tse; Damien C Croteau-Chonka; Erick Forno; Augusto A Litonjua; Benjamin A Raby; Wei Chen; Qi Yan; Nadia Boutaoui; Edna Acosta-Pérez; Lydiana Avila; Scott T Weiss; Manuel Soto-Quiros; Michelle M Cloutier; Donglei Hu; Maria Pino-Yanes; Sally E Wenzel; Melissa L Spear; Jay K Kolls; Esteban G Burchard; Glorisa Canino; Juan C Celedón Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Carlos A Vaz Fragoso; Todd M Manini; John A Kairalla; Thomas W Buford; Fang-Chi Hsu; Thomas M Gill; Stephen B Kritchevsky; Mary M McDermott; Jason L Sanders; Steven R Cummings; Gregory J Tranah Journal: Exp Gerontol Date: 2018-12-01 Impact factor: 4.032
Authors: Maria C Mirabelli; John S Preisser; Laura R Loehr; Sunil K Agarwal; R Graham Barr; David J Couper; John L Hankinson; Noorie Hyun; Aaron R Folsom; Stephanie J London Journal: Respir Med Date: 2016-02-11 Impact factor: 3.415
Authors: John S House; Huiling Li; Laura M DeGraff; Gordon Flake; Darryl C Zeldin; Stephanie J London Journal: FASEB J Date: 2014-10-23 Impact factor: 5.191
Authors: Adel Boueiz; Sharon M Lutz; Michael H Cho; Craig P Hersh; Russell P Bowler; George R Washko; Eitan Halper-Stromberg; Per Bakke; Amund Gulsvik; Nan M Laird; Terri H Beaty; Harvey O Coxson; James D Crapo; Edwin K Silverman; Peter J Castaldi; Dawn L DeMeo Journal: Am J Respir Crit Care Med Date: 2017-03-15 Impact factor: 21.405
Authors: Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf Journal: Am J Respir Cell Mol Biol Date: 2014-11 Impact factor: 6.914